Thus, our results indicate that LRP1 controls GluA1-mediated synaptic formation, integrity and function, and disturbances of this pathway may be partially involved in synaptic deficits in neurodegenerative diseases. The gene discussed is LRP1; the disease is neurodegenerative disease.